The abstract is read at the publisher; the summary is JClub's.
SOAT1-linked cholesterol esterification is associated with immune evasion and recurrence in hepatocellular carcinoma, and SOAT1 inhibition sensitizes liver cancer to CD8+ T cell attack.
- Why it matters: Recurrence after liver transplantation is a major challenge in HCC, but drivers of immune escape that predict or enable recurrence are not well defined.
- What they did: The study integrated proteomic profiling of human HCC samples with recurrence status and T cell killing assays, then tested genetic or pharmacologic SOAT1 inhibition with CD8+ T cell, anti-PD-1, and CAR-T approaches.
- The result: SOAT1 inhibition increased intratumoral CD8+ T cell infiltration and improved immunotherapy efficacy, linked to disrupted cholesterol/lipid metabolism, reduced unsaturated fatty acids and prostaglandin E2, and impaired antioxidant capacity under immune attack.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.